SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: Zeev Hed who wrote (41551)3/18/2002 1:40:45 PM
From: LTK007  Respond to of 99280
 
Aventis FDA decision tomorrow. One shorter was on ABC news last night saying they will not get approval for their cold medicine.
Argument is strong from my view that it does not get approval.The best they can prove is it cuts a cold's duration by one day .
Point is,if not approved will it actually damage the Aventis, is it something they are counting on big time?? max



To: Zeev Hed who wrote (41551)3/18/2002 1:45:58 PM
From: LTK007  Read Replies (2) | Respond to of 99280
 
i see drug(Picovir) is a partnership between AVE and VPHM, looks like VPHM has a lot more at stake.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News